Literature DB >> 15043853

Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C virus.

Motoh Iwasa1, Kazuko Iwata, Masahiko Kaito, Jiro Ikoma, Mika Yamamoto, Masaki Takeo, Makoto Kuroda, Naoki Fujita, Yoshinao Kobayashi, Yukihiko Adachi.   

Abstract

OBJECTIVES: A diet restrictive in total calories, fat, iron, and protein intake reduces serum alanine aminotransferase levels in patients with long-term hepatitis C virus infection. However, whether long-term dietary therapy causes adverse effects such as malnutrition and anemia due to a shortage of energy intake is not clear. We evaluated the balance of energy intake and changes in physical and hematologic indices of nutrition after a long-term dietary therapy.
METHODS: Twenty-two patients with long-term hepatitis C virus infection that did not respond to or who were able or unwilling to take interferon therapy were enrolled in this study. Our prescriptions included 7 mg/d or less of iron, 30 kcal. kg(-1). d(-1) of energy, 1.1 to 1.2 g. kg(-1). d(-1) of protein, and a fat energy fraction of 20%. Patients were followed for 24 mo.
RESULTS: Mean body fat percentage was 24.6% at entry and was significantly reduced after the diet prescription. Mean serum ferritin decreased significantly from 376 ng/mL at entry to 141 ng/mL after 24 mo. Mean serum alanine aminotransferase levels decreased significantly from 66 to 49 IU/L. Mean levels of hemoglobin, serum albumin, and cholinesterase did not change significantly during the follow-up period.
CONCLUSIONS: These results suggest that restriction of energy, fat, iron, and protein intakes is safely tolerated, so its long-term use should be recommended to patients with long-term infection with hepatitis C virus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15043853     DOI: 10.1016/j.nut.2003.12.009

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  9 in total

1.  Iron content and consumption of health foods by patients with chronic hepatitis C.

Authors:  Kazuko Iwata; Motoh Iwasa; Nagisa Hara; Aki Matsumoto; Yoshinao Kobayashi; Shozo Watanabe; Yukihiko Adachi; Masahiko Kaito
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

2.  Molecular mechanism of iron metabolism and overload in chronic hepatitis C.

Authors:  Masahiko Kaito
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

Review 3.  Interaction between hepatitis C virus and metabolic factors.

Authors:  Yasunori Kawaguchi; Toshihiko Mizuta
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

Review 4.  Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.

Authors:  Abdel-Rahman El-Zayadi; Mahmoud Anis
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

Review 5.  Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization.

Authors:  Takumi Kawaguchi; Michio Sata
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

6.  Increased oxidative stress, decreased total antioxidant capacity, and iron overload in untreated patients with chronic hepatitis C.

Authors:  Danielle Venturini; Andréa Name Colado Simão; Décio Sabbatini Barbosa; Edson Lopes Lavado; Victor Emanuel Soares Narciso; Isaias Dichi; Jane Bandeira Dichi
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

7.  Nutrition therapy for liver diseases based on the status of nutritional intake.

Authors:  Kenichiro Yasutake; Motoyuki Kohjima; Manabu Nakashima; Kazuhiro Kotoh; Makoto Nakamuta; Munechika Enjoji
Journal:  Gastroenterol Res Pract       Date:  2012-11-14       Impact factor: 2.260

8.  Treatment Options for Hepatitis C Infection in Children.

Authors:  Aymin Delgado-Borrego; Maureen M. Jonas
Journal:  Curr Treat Options Gastroenterol       Date:  2004-10

9.  Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C.

Authors:  H Tanaka; N Fujita; R Sugimoto; N Urawa; S Horiike; Y Kobayashi; M Iwasa; N Ma; S Kawanishi; S Watanabe; M Kaito; Y Takei
Journal:  Br J Cancer       Date:  2008-01-29       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.